###begin article-title 0
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
Association of TNFA Promoter Region Haplotype in Behcet's Disease
###end article-title 0
###begin p 1
###xml 390 394 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 628 632 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 721 733 713 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 735 741 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 746 752 738 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 807 808 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 824 825 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 841 842 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 882 886 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 1001 1005 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 1100 1112 1092 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 1114 1120 1106 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 1122 1128 1114 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*C</italic>
###xml 1133 1139 1125 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 1243 1247 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 658 666 <span type="species:ncbi:9606">patients</span>
Although the etiology of Behcet's Disease (BD; MIM 109650) remains to be clearly elucidated, levels of tumor necrosis factor alpha (TNF-alpha) have been reported to be significantly elevated in BD patients, and TNF-alpha blockers have been demonstrated to exhibit some degree of therapeutic efficacy for a certain subset of BD sufferers. In this study, we have conducted an analysis of the TNFA haplotypes in the promoter response element that affect the binding affinity of specific transcription factors, in order to characterize their association with the clinical features of BD. Six polymorphisms in the promoter region of TNFA were genotyped in 254 BD patients and 344 control subjects, via the PCR-RFLP technique. TNFA -1031*C, -863*A and -308*G alleles were associated with an increased risk of BD (p=0.030, OR=1.4; p=0.008, OR=1.5; p=0.010, OR=1.8, respectively). The sole TNFA haplotype -1031C-863A-857C-376G-308G-238G, was associated with a 1.6 fold increase in the risk of BD, whereas the TNFA haplotype -1031T-863C-857C-376G-308A-238G was associated with a 0.6 decreased risk of BD. The TNFA -1031*C, -863*A, -857*C and -308*G alleles were significantly associated with BD. The findings of this study, collectively, indicate that TNFA haplotypes in the promoter response elements may exert significant influence on susceptibility to BD.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1074 1075 1074 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Behcet's Disease (BD; MIM 109650) is a chronic multisystem inflammatory disorder of unclear etiology, which is characterized by primary features including recurrent oral and genital ulcers as well as skin and ocular lesions. Other minor manifestations of BD include arthritis, large vessel involvement (LVI), and lesions of central nervous system (CNS) and gastrointestinal (GI) tract. The mean age of onset of BD is in the early 30s, and the male-to-female ratio varies with ethnicity (1). Although the precise pathogenesis of BD remains a matter of some controversy, genetic, immunological, and environmental factors have been suggested to contribute to the development of BD (2). Several susceptibility variant genetic alleles, including alleles of Th1 cytokine-associated genes, have been recognized for their effects on the clinical symptoms of BD. A recent study of Turkish multicase families identified several BD susceptibility loci, via whole-genome linkage analysis. The loci with the strongest association with BD were detected at positions 6p22-24 and 12p12-13 (3).
###end p 3
###begin p 4
###xml 338 342 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 604 605 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 606 607 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 664 668 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 768 769 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 770 771 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1158 1159 1134 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1518 1520 1482 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1522 1524 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1771 1773 1731 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1775 1777 1735 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 296 304 <span type="species:ncbi:9606">patients</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
###xml 1345 1353 <span type="species:ncbi:9606">patients</span>
Tumor necrosis factor alpha (TNF-alpha) is a multifunctional, pro-inflammatory cytokine, which performs a variety of functions in innate immune response, including activation of macrophages and apoptosis, which appears to be responsible for the recurrent inflammatory reactions encountered in BD patients. The promoter polymorphism of theTNFA gene, which is located on chromosome 6p21.3, has been associated with the expression of TNF-alpha. TNF-alpha levels tend to be significantly elevated in active BD patients, and increased production of TNF-alpha have been associated with clinical deterioration (4,5). Several single nucleotide polymorphisms (SNPs) in the TNFA promoter region appear to alter transcription efficiency in response to specific external stimuli (6-8). Excessive or insufficient TNF-alpha production might be responsible for the variable patterns of the pathogenesis of this disease. These SNPs, as well as TNF-alpha overproduction, have been associated with susceptibility to or with the severity of, both inflammatory diseases and autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and Crohn's disease (9). There is, currently, a large body of evidence from in vitro experiments which suggests that TNF-alpha is produced at higher levels in both the monocytes and gamma/delta T cells of BD patients in response to lipopolysaccharide treatment than has been observed in control subjects. However, the mechanism underlying this phenomenon remains to be determined (10, 11). Also, infliximab (monoclonal anti-TNF-alpha antibody) and etanercept (a dimeric soluble p75 TNF receptor) have demonstrated a high degree of therapeutic efficacy for suffers of BD coupled with uveitis, intestinal ulcers, and orogenital ulcers (12, 13).
###end p 4
###begin p 5
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 422 424 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 426 428 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 445 452 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-376G&gt;A</italic>
###xml 457 464 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308G&gt;A</italic>
###xml 562 563 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 564 566 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 567 569 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 652 656 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
Researchers have been attempting for several years to determine whether polymorphisms of the TNFA promoter region influence the expression of TNF-alpha in BD or its susceptibility or its severity and clinical features. The results of these allelic and genotypic associations, however, are somewhat contradictory, as the implicated polymorphic sites and allele frequencies appear to vary substantially among ethnic groups (14, 15). Most notably, -376G>A and -308G>A are either completely absent or quite rare among Asians, including the Koreans and the Japanese (6,16,17). Therefore, this study was focused specifically on the haplotypic association of TNFA promoter response elements with the risks and clinical features of BD.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Subjects
###end title 7
###begin p 8
###xml 601 603 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Two hundred fifty-four patients (130 males and 124 females) from 16 to 66 yr of age registered at the Behcet's Disease Specialty Clinic of Severance Hospital at the Yonsei University College of Medicine and the Ajou University School of Medicine and 344 healthy Korean controls were included in this case-control study. The youngest onset of BD was 3 yr old and the oldest onset was 58 yr old and the mean age of disease onset was 33.2+/-10.4 yr old. BD was diagnosed according to the clinical criteria of the International Study Group for Behcet's Disease or the revised criteria of Behcet's Disease(18).
###end p 8
###begin title 9
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
Genotyping of TNFA
###end title 9
###begin p 10
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 178 187 178 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031 T&gt;C</italic>
###xml 189 198 189 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863 C&gt; A</italic>
###xml 200 208 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857 C&gt;T</italic>
###xml 210 218 210 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-376 G&gt;A</italic>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308 G&gt;A</italic>
###xml 233 241 233 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-238 G&gt;A</italic>
###xml 408 417 408 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031 T&gt;C</italic>
###xml 543 546 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bbs</italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 577 585 577 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863 C&gt;A</italic>
###xml 704 707 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tai</italic>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 827 834 827 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857C&gt;T</italic>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinc</italic>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1034 1037 1034 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 1063 1067 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-376</italic>
###xml 1088 1091 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsp</italic>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1237 1240 1237 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nco</italic>
###xml 1262 1266 1262 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308</italic>
###xml 1266 1269 1266 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 1366 1369 1366 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 1539 1542 1539 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hpa</italic>
###xml 1565 1567 1565 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Genomic DNA was extracted from peripheral blood by using a QIAamp Blood Mini kit (Quiagen, Valencia, CA, U.S.A.). Six SNPs in the promoter region of TNFA gene at the position of -1031 T>C, -863 C> A, -857 C>T, -376 G>A, -308 G>A and -238 G>A (according to GenBank accession No. AB088112) were analyzed by using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods. The -1031 T>C was amplified with PCR by using primers 5'-ACAAGGCTGACCAAGAGAGAA-3' and 5'-GTCCCCATACTCGACTTTCAT-3'and was digested with the BbsI restriction enzyme (19). The -863 C>A was amplified by using primers 5'-GGCTCTGAGGAATGGGTTAC-3'and 5'-CTACATGGCCCTGTCTTCGTTACG-3' and was digested with the TaiI restriction enzyme (20). The reverse primer contained one mismatched nucleotide sequence (underlined). Genotyping for -857C>T was conducted by using the forward primer 5'-AAGTCGAGTATGGGGACCCCCCGTTAA-3'and the reverse primer 5'-CCCCAGTGTGTGGCCATATCTTCTT-3'which made it possible to use the restriction enzyme HincII (19). The G>A substitution at position -376 was analyzed by the Tsp509I restriction enzyme by using the primers, 5'-CCCCGTTTTCTCTCCCTCAA-3'and 5'-TGTGGTCTGTTTCCTTCTAA-3'(21). The polymorphic region containing the NcoI restriction site at -308G>A was amplified by using primers 5'-AGGCAATAGGTTTTGAGGGCCAT-3'and 5'-TCCTCCCTGCTCCGATTCCG-3'. The G>A transition polymorphism at position -238 was examined by PCR using primers 5'-CCCAGAAGACCCCCCTCGGAACC-3'and 5'-ACCTTCTGTCTCGGTTTCTTCTCCATCGC-3'and was digested with the HpaII restriction enzyme (19). The digested PCR products were electrophoresis on an 8% or 5% polyacrylamide gel and were stained with ethidium bromide to visualize the DNA fragments.
###end p 10
###begin title 11
Statistical analysis
###end title 11
###begin p 12
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 266 267 264 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 432 434 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 439 440 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
The Hardy-Weinberg equilibrium and Linkage disequilibrium coefficient Lewontin's D'(|D'|) were performed with the R program v.1.9.1 (). The statistical significance of the difference in TNFA allele frequencies between BD patients and controls was examined by the chi2 or Fisher's exact test by using SAS version 8.1 (SAS Institute, Cary, NC, U.S.A.). Haplotypes of each individual were inferred by using the PHASE program, v.2.0.1 (22). A p-value of less than 0.05 was considered statistically significant.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin p 14
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 264 271 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 402 414 402 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -376G&gt;A</italic>
###xml 465 477 465 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 490 496 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 555 556 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 585 586 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 602 603 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 775 782 775 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 840 846 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-238*A</italic>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
A total of 254 Korean BD patients and 344 control subjects were analyzed for six SNPs in the TNFA promoter region. The genotype and allele frequencies of the regulatory response element promoter polymorphisms TNFA gene of the BD patients and controls are shown in Table 1. Distributions of the genotypes of both groups agree with those predicted under the conditions of Hardy-Weinberg equilibrium. The TNFA -376G>A was not polymorphic in the Korean population. The TNFA -1031*C, -863*A and -308*G alleles are shown to be significantly associated with BD (p=0.030, odds ratio [OR]=1.4; p=0.008, OR=1.5; p=0.010, OR=1.8, respectively). They were significantly higher in the BD patients suffering from major symptoms (OR=1.4-1.9) and arthritis(OR=1.4-2.9) than in the controls (Table 2). There was no association between the presence of minor -238*A allele and the symptoms of BD except for BD with GI lesions.
###end p 14
###begin p 15
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 184 196 184 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*C</italic>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 514 526 514 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 539 545 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*C</italic>
###xml 654 660 654 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
The age at which an individual first manifests major symptoms of the BD appears to be genetically influenced. The TNFA promoter SNPs influenced the age onset (before 20 yr) in BD. The TNFA -1031*C, -863*A and -857*C alleles were shown to have a significantly higher association among the BD patients whose onset age is younger than 20 yr old when compared with those whose onset age is after 20 yr old (p=0.03-0.04, OR=1.6-2.5). Significant differences between BD and controls were observed in the distribution of TNFA -1031*C, -863*A and -857*C did show significantly higher ORs in the early onset age group than the later onset age group (OR=1.6-2.5) (Fig. 1).
###end p 15
###begin p 16
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 84 91 84 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 98 109 98 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA-1031*T</italic>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*C</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*C</italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*C</italic>
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*C</italic>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 305 341 305 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031T-863C-857C-376G-308G-238G</italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 575 611 575 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031C-863A-857C-376G-308G-238G</italic>
###xml 651 663 651 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 665 671 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 749 785 749 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031T-863C-857C-376G-308A-238G</italic>
###xml 861 868 861 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 511 519 <span type="species:ncbi:9606">patients</span>
TNFA promoter polymorphisms showed linkage disequilibrium in the Korean population (Table 3). The TNFA-1031*T was strong associated with -863*C (p<0.0001) and -857*C (p<0.0001). The -863*C was in linkage disequilibrium with the -857*C (p=0.0003). Among 22 estimated haplotypes, the most common haplotype, TNFA -1031T-863C-857C-376G-308G-238G (55%) and six common TNFA haplotypes were observed in the Korean population. The overall haplotype distributions were found to be significantly different between the BD patients and the controls by the permutation test (p=0.02). The TNFA -1031C-863A-857C-376G-308G-238G haplotype containing the three alleles TNFA -1031*C, -863*A and -308*G was found to be significantly associated with BD. Conversely, the TNFA -1031T-863C-857C-376G-308A-238G which did not have these alleleic polymorphisms was protective against BD (Table 4).
###end p 16
###begin p 17
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 306 342 306 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031C-863A-857C-376G-308G-238G</italic>
###xml 377 384 377 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031*C</italic>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 681 717 681 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031T-863C-857C-376G-308A-238G</italic>
###xml 821 822 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 849 856 849 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 874 910 874 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031T-863C-857T-376G-308G-238G</italic>
###xml 915 951 915 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031C-863C-857C-376G-308G-238A</italic>
###xml 1122 1129 1122 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
###xml 970 978 <span type="species:ncbi:9606">patients</span>
###xml 1071 1079 <span type="species:ncbi:9606">patients</span>
The patients were characterized by clinical features whose major/minor symptoms were oral, genital ulcers, skin, ocular lesions, arthritis, and LVI. The CNS and GI lesions are rare. We investigated the clinical features of the TNFA haplotypepositive individuals in terms of the frequency of the haplotype, TNFA -1031C-863A-857C-376G-308G-238G, which contains the three alleles -1031*C, -863*A and -308*G. Being compared with the controls, it was significantly over-represented among patients (OR=1.6-3.0) who suffered from oral and genital ulcers, skin and ocular lesions, arthritis and CNS but not among those who suffered from LVI or GI lesions. On the other hand, the haplotype TNFA -1031T-863C-857C-376G-308A-238G which does not carry those alleles were shown to significantly reduce the risk of BD than in controls (p=0.029-0.013, OR=0.4-0.6) (Table 4). Frequencies of TNFA -1031T-863C-857T-376G-308G-238G and TNFA -1031C-863C-857C-376G-308G-238A haplotypes in the patients with CNS or GI lesions significantly differed from those in the controls, but the number of patients was too small for a statistical analysis (Table 4).
###end p 17
###begin title 18
DISCUSSION
###end title 18
###begin p 19
###xml 183 187 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 579 583 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 603 615 595 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 617 623 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 628 634 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 672 684 664 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -376G&gt;A</italic>
###xml 689 696 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-238G&gt;A</italic>
###xml 854 866 846 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 983 985 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1061 1073 1053 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -376G&gt;A</italic>
###xml 1075 1082 1067 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308G&gt;A</italic>
###xml 1087 1094 1079 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-238G&gt;A</italic>
###xml 1146 1148 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1149 1151 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1152 1154 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1189 1193 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 1208 1244 1200 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031C-863A-857C-376G-308G-238G</italic>
###xml 1274 1281 1266 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031*C</italic>
###xml 1283 1289 1275 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 1294 1300 1286 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308*G</italic>
###xml 1364 1400 1356 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031T-863C-857C-376G-308A-238G</italic>
###xml 1607 1609 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1722 1726 1714 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 1740 1747 1732 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031*C</italic>
###xml 1749 1755 1741 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 1760 1766 1752 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*C</italic>
###xml 474 482 <span type="species:ncbi:9606">patients</span>
###xml 920 928 <span type="species:ncbi:9606">patients</span>
###xml 1047 1055 <span type="species:ncbi:9606">patients</span>
###xml 1575 1583 <span type="species:ncbi:9606">patients</span>
Both clinical and polymorphism-focused studies have uncovered evidence suggesting that TNF-alpha functions as a mediator in the initiation and propagation of BD. Polymorphisms of the TNFA promoter region have been associated with BD in several ethnic groups, but it remains somewhat uncertain as to whether this is the results of the existence of susceptibility sites, or to the level of TNF-alpha expression. In this study, a significant difference was observed between BD patients and controls with regard to the polymorphisms of the regulatory response promoter region of the TNFA gene. The alleles, TNFA -1031*C, -863*A and -308*G were closely associated with BD, but TNFA -376G>A and -238G>A were not significantly associated among Korean sufferers of BD. These results are consistent with findings of studies employing different ethnic groups. The TNFA -1031*C allele was strongly association with BD in Caucasian patients, in a previous study conducted in the United Kingdom (23). The other previous studies involving Turkish and Caucasian patients, the TNFA -376G>A, -308G>A and -238G>A alleles were not significantly associated with BD (15,23-25). In studies of haplotypes of the TNFA promoter, the TNFA -1031C-863A-857C-376G-308G-238G haplotype, which harbors the -1031*C, -863*A and -308*G alleles, was significantly associated with BD. Conversely, the TNFA -1031T-863C-857C-376G-308A-238G haplotype, which does not harbor the aforementioned allelic polymorphisms, was associated with a reduced susceptibility to BD. The same results were reported in Caucasian BD patients in the United Kingdom (23). We compared the risk of BD between the early onset age group and the later onset of group, with regard to the TNFA alleles. The -1031*C, -863*A and -857*C alleles were detected with a significantly greater frequency in the former than in the latter.
###end p 19
###begin p 20
###xml 130 132 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 695 697 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1507 1515 1483 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031T&gt;C</italic>
###xml 1517 1524 1493 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863C&gt;A</italic>
###xml 1529 1536 1505 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857C&gt;T</italic>
###xml 1544 1548 1520 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 1729 1739 1705 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031</italic>
###xml 1741 1745 1717 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863</italic>
###xml 1750 1754 1726 1730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857</italic>
###xml 1868 1876 1844 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-1031T&gt;C</italic>
###xml 1878 1885 1854 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863C&gt;A</italic>
###xml 1890 1897 1866 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857C&gt;T</italic>
###xml 1958 1965 1934 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-376G&gt;A</italic>
###xml 1967 1974 1943 1950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-308G&gt;A</italic>
###xml 1978 1985 1954 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-238G&gt;A</italic>
###xml 1987 1988 1963 1964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1989 1991 1965 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1992 1994 1968 1970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1995 1997 1971 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 2102 2104 2078 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 679 684 <span type="species:ncbi:9606">human</span>
Inflammation in cases of BD is believed to be mediated by cytokines derived from T-helper type 1 lymphocytes, including TNF-alpha(26). It appears that disease activity can be significantly associated with the secretion of pro-inflammatory mediators, as the result of the direct activation of circulating monocytes. The pro-inflammatory cytokine, TNF-alpha , triggers a signaling cascade, converging on the activation of the NF-kappaB transcription factor, which is also involved in a variety of features of immune response, which in turn constitutes the basis for a host of physiological and pathological processes. The TNF-alpha/NF-kappaB pathway also appears to be relevant to human diseases (27). The enhanced/silenced expression of pro-inflammatory cytokines indicates the presence of a defect in the normal regulatory mechanisms, and this may have a genetic basis. Much of the control of gene expression appears to involve transcription factors (trans-acting) bound to proximal promoter regulatory response sequences (cis-acting). Gene expression is mediated by several sets of cis-acting regulatory regions, including the core or proximal promoter region, and the response elements. The response elements modulate transcription in response to specific external stimuli, including heat shock 70 or interferon-gamma. The response elements are normally located a short distance upstream of the promoter elements. Allele-specific elements may bind the transcriptional factors, OCT-1 and NF-kappaB, in the -1031T>C, -863C>A and -857C>T of the TNFA regulatory response promoter region, which are thought to be involved in a variety of the immune response functions. Although the roles of the allele-dependent binding elements of TNFA -1031, -863 and -857 SNPs have yet to be precisely delineated, the susceptible sites associated with the development of BD are in the -1031T>C, -863C>A and -857C>T SNPs of the regulatory response promoter region, and not in -376G>A, -308G>A or -238G>A (6,15,28-30). These SNPs also evidenced no relationship with the degree of severity of the clinical features of BD (15).
###end p 20
###begin p 21
###xml 517 526 513 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 HYPA</italic>
###xml 659 661 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 662 664 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 729 741 721 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031*C</italic>
###xml 743 749 735 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-863*A</italic>
###xml 753 759 745 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-857*T</italic>
###xml 814 816 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 891 922 883 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031C-863A-857C-376G-308G</italic>
###xml 926 935 918 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL2 HY--</italic>
###xml 937 943 929 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-550*G</italic>
###xml 945 951 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-221*G</italic>
###xml 1038 1039 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1343 1347 1331 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 999 1006 <span type="species:ncbi:9606">patient</span>
The pro-inflammatory cytokines, TNF-alpha and mannosebinding lectin (MBL), are potent inducers of inflammation. Elevated levels of these cytokines are frequently associated with the activation of macrophages, thereby influencing the severity of inflammatory responses. Both of these pro-inflammatory cytokines induce local inflammatory responses, and also exert systemic effects. The over-expression of these cytokines may be responsible for the pathogenesis of recurrent BD. It has been reported previously that the MBL2 HYPA haplotype, which induces an elevate expression of MBL, was related to susceptibility to BD, and also to the early onset of disease (31,32). TNF-alpha production tended to be elevated in carriers of the TNFA -1031*C, -863*A or -857*T alleles, who also suffered from severe periodontitis (19). The frequency with which individuals were determined to harbor both the TNFA -1031C-863A-857C-376G-308Gand MBL2 HY-- (-550*G, -221*G) haplotypes was significantly higher in the BD patient group than among the controls (p=0.004). The elevated production of TNF-alpha and MBL2 haplotypes might serve to accelerate recurrent inflammation, or may play a critical pathogenic role in initiating immune responses, which might also result in the development of BD. A host of genes appear to be related to BD susceptibility, and the TNFA promoter haplotypes appear to be fairly important markers with regard to their association with BD.
###end p 21
###begin p 22
###xml 60 86 60 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA -1031C-863A-857C-308G</italic>
In conclusion, the findings of this study indicate that the TNFA -1031C-863A-857C-308G haplotype can be confidently associated with the development of BD as well as early age of onset. This haplotype was also determined to be responsible for the enhanced inflammatory reactions seen in cases of BD involving primary symptoms.
###end p 22
###begin p 23
###xml 41 68 41 68 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sungshin Women's University</funding-source>
###xml 78 93 78 93 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2004-1-31-007/1</award-id>
###xml 50 55 <span type="species:ncbi:9606">Women</span>
This study was supported by a grant from Sungshin Women's University in 2004 (2004-1-31-007/1).
###end p 23
###begin article-title 24
###xml 20 28 <span type="species:ncbi:9606">patients</span>
Influence of sex on patients with Behcet's disease in Korea
###end article-title 24
###begin article-title 25
Immunology and functional genomics of Behcet's disease
###end article-title 25
###begin article-title 26
Whole-genome screening for susceptibility genes in multicase families with Behcet's disease
###end article-title 26
###begin article-title 27
Serum interleukin 18 and tumor necrosis factor-alpha levels are increased in Behcet's disease
###end article-title 27
###begin article-title 28
Cytokines in Behcet's disease
###end article-title 28
###begin article-title 29
###xml 46 51 <span type="species:ncbi:9606">human</span>
Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese
###end article-title 29
###begin article-title 30
###xml 33 38 <span type="species:ncbi:9606">human</span>
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
###end article-title 30
###begin article-title 31
The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription
###end article-title 31
###begin article-title 32
Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene
###end article-title 32
###begin article-title 33
Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects
###end article-title 33
###begin article-title 34
Role of gamma/delta T lymphocytes in the development of Behcet's disease
###end article-title 34
###begin article-title 35
Effect of infliximab on sight-threatening panuveitis in Behcet's disease
###end article-title 35
###begin article-title 36
Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study
###end article-title 36
###begin article-title 37
###xml 20 25 <span type="species:ncbi:9606">human</span>
Polymorphism of the human TNF-alpha promoter; random variation or functional diversity?
###end article-title 37
###begin article-title 38
Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behcet's disease
###end article-title 38
###begin article-title 39
Antithetical effect of tumor necrosis factor-alpha gene polymorphism on coal workers' pneumoconiosis (CWP)
###end article-title 39
###begin article-title 40
###xml 62 70 <span type="species:ncbi:9606">patients</span>
TNF and TNF receptor polymorphisms in Korean Behcet's disease patients
###end article-title 40
###begin article-title 41
Criteria for diagnosis of Behcet's disease
###end article-title 41
###begin article-title 42
Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese
###end article-title 42
###begin article-title 43
A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha
###end article-title 43
###begin article-title 44
###xml 114 133 <span type="species:ncbi:6183">Schistosoma mansoni</span>
No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection
###end article-title 44
###begin article-title 45
A new statistical method for haplotype reconstruction from population data
###end article-title 45
###begin article-title 46
Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms?
###end article-title 46
###begin article-title 47
Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behcet's disease
###end article-title 47
###begin article-title 48
TNF-alpha gene polymorphisms in Behcet's disease
###end article-title 48
###begin article-title 49
Behcet's disease: an update on the pathogenesis
###end article-title 49
###begin article-title 50
###xml 37 42 <span type="species:ncbi:9606">human</span>
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway
###end article-title 50
###begin article-title 51
Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region
###end article-title 51
###begin article-title 52
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF (-kappa) B transcription factors
###end article-title 52
###begin article-title 53
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease
###end article-title 53
###begin article-title 54
Association of HYPA haplotype in the mannose-binding lectin gene-2 with Behcet's disease
###end article-title 54
###begin article-title 55
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
###end article-title 55
###begin p 56
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
Allele frequency of the TNFA promoter in BD onset age.
###end p 56
###begin p 57
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Genotype and allele frequencies of the TNFA promoter SNPs in BD patients and controls
###end p 57
###begin p 58
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
The allele frequency of TNFA for clinical feature of BD patients
###end p 58
###begin p 59
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
Linkage disequilibria (|D'|) among SNP of TNFA in the Korean population (n=344)
###end p 59
###begin p 60
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
|D'| value is given above the diagonal; p value is given below the diagonal.
###end p 60
###begin p 61
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFA</italic>
Clinical features associated with TNFA haplotype
###end p 61

